Crown Reserve Acquisition Corp. I（CRAC）股票分析

AI 分析 of Crown Reserve Acquisition Corp. I (CRAC)

持有

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.

估值指标

Crown Reserve Acquisition Corp. I（CRAC）当前预期市盈率为 0.00，5 年平均预期市盈率为。

预期市盈率

5 年均值 P/E

当前P/E

0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA

当前EV/EBITDA

0.00

预期市销率

5 年均值 P/S

当前P/S

0.00

持有 CRAC 的大户

W

W. R. Berkley Corporation

+ 持有CRAC

-1.34%

3个月收益率

P

Polar Asset Management Partners Inc.

+ 持有CRAC

-2.91%

3个月收益率

CRAC 常见问题 —— 由 Alphio AI 解答

Crown Reserve Acquisition Corp I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focused industries include pharma, medical technology and medical equipment, and healthcare information technology (IT) industries. The Company is not engaged in any business operation and does not have any revenues. It operates in the Financials sector.

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.